Despite more evidence is warranted to elucidate how CRP affects cognitive function in the neuropathology of AD, our result suggests that increased CRP level may indicate an appropriate immune response function among patients who already with cognitive impairment, contributing to slower cognitive decline in the AD progression. The gene discussed is CRP; the disease is Cognitive impairment.